U.S. Stock News

Aptiv recently reported second-quarter 2026 results showing sales growth but weaker net income, issued cautious third-quarter guidance, and continued its sizeable share repurchase program. Soon after, Aptiv was placed on the Zacks Rank #5 (Strong Sell) list following a 10% cut to current-year earnings estimates over 60 days, highlighting mounting concerns over profitability despite revenue growth and buybacks. We will now explore how the recent Zacks Rank downgrade and earnings estimate cuts...

Global yields are shifting as US Treasury buybacks increase and long term interest rates adjust. When money moves like this, capital often rewards leaders who can react quickly and keep a clear long term focus. Founder led companies tend to have both. This article explains why that matters now and highlights 3 stocks from our Founder Led Companies screener that show how this edge can play out. The 3 founder led stocks in the article below are only a sample, and the full screen surfaced 1,441...

PriceSmart stock has delivered a strong 130.5% total return over the past three years, yet the valuation checks currently lean expensive rather than pointing to an obvious bargain. Over the last three years, PriceSmart has returned 130.5%, which sets a high bar for any further gains to be justified by fundamentals. Future revenue growth and margin consistency can support the current share price, while any setback in execution or pressure on consumer spending may make today’s valuation harder...

With 30 year Treasury yields recently touching levels last seen in 2007 and Washington stepping up long term debt buybacks, income stocks tied to interest rates are back under the spotlight. For investors who care about both dividends and capital risk, that mix of policy moves and market signals can feel like a crossroads. This article walks through three stocks from our Interest Rate Sensitive Dividend Stocks screener that look especially exposed to these shifts and explains what that might...

Vicor (VICR) is back on investors’ radar after analysts collectively raised earnings estimates, a shift that coincides with recent share price gains and a Zacks Rank #2, reflecting this improved outlook. See our latest analysis for Vicor. Over the past year Vicor has delivered a very large 1 year total shareholder return of 367.52%, while recent momentum has cooled with the share price down 10.34% over one day and 18.99% over ninety days at US$217.35. If Vicor's sharp swings have you thinking...

J. M. Smucker (SJM) is drawing fresh investor attention after introducing modernized branding and new product formats for its Jif peanut butter line. This marks the first major refresh in more than 30 years. See our latest analysis for J. M. Smucker. The fresh Jif branding arrives at a time when J. M. Smucker’s short term momentum is building, with a 30 day share price return of 9.19% and a 90 day share price return of 20.54%, while the 1 year total shareholder return sits at 13.13%. If the...

Unusual Machines (UMAC) recently reported second quarter and first half 2026 earnings, drawing fresh attention to the stock as investors weigh a sharp shift in reported profitability over the six month period. See our latest analysis for Unusual Machines. Unusual Machines has seen sharp swings around these earnings, with the 1-day share price return declining 7.46%, while the 30-day share price return sits at 62.83% and the 1-year total shareholder return is 194.18%. This points to momentum...

Lamar Advertising (LAMR) drew fresh attention after reporting second quarter 2026 results along with updated full year guidance. The company released new net income and diluted EPS ranges for the year ending December 31, 2026. See our latest analysis for Lamar Advertising. At a share price of $153.98, Lamar Advertising has a 1-day share price return of 1.49% and a year to date share price return of 24.06%, while the 5 year total shareholder return of 74.54% points to momentum that has built...

Southern Copper recently reported record second-quarter 2026 results, with net sales reaching US$4.29 billion, net income climbing to US$1.67 billion, and the quarterly cash dividend lifted to US$1.10 per share. These records, combined with the dividend increase, highlight strong operational performance and management’s confidence in the company’s ability to sustain its earnings and payouts. Next, we’ll explore how these record quarterly results and the higher dividend affect Southern...

Regulatory milestone in Türkiye refocuses attention on Freedom Holding Freedom Holding (FRHC) is back on investors’ radar after its Turkish subsidiary received a broad operating license from the Capital Markets Board of Türkiye, opening the door to new investment services in the country. See our latest analysis for Freedom Holding. At a share price of US$159.15, Freedom Holding has seen a 7 day share price return of 5.17% and a year to date share price return of 28.11%, while the 1 year total...

Hawaiian Electric Industries (HE) drew fresh attention on August 7, 2026, after reporting second quarter and year-to-date earnings that showed higher revenue, net income, and earnings per share compared with a year earlier. See our latest analysis for Hawaiian Electric Industries. Despite the stronger second quarter figures, Hawaiian Electric Industries’ share price has been under pressure, with a 30 day share price return of down 11.42% and a 90 day share price return of down 14.46%, while...

Ondas stock has delivered an extremely strong move over the past three years, yet the broader valuation checks lean expensive rather than cheap, which puts recent enthusiasm under the microscope. The share price is up more than 8x over the past three years, which puts extra focus on whether current expectations already reflect much of the growth story. Recent contract wins and acquisitions can support expectations for higher revenue over time. However, the wider loss reported alongside this...

Autohome Inc. has reported past earnings for the second quarter and six months ended June 30, 2026, with quarterly revenue of CNY 1,198.01 million and net income of CNY 247.81 million, both lower than the same period a year earlier, while basic earnings per share from continuing operations fell to CNY 2.2. Over the first half of 2026, Autohome’s net income dropped to CNY 292.06 million and basic earnings per share from continuing operations declined to CNY 2.56, highlighting pressure on...

International Business Machines (IBM) has drawn fresh investor attention after reporting a fiscal Q2 2026 revenue shortfall and cutting its 2026 revenue growth guidance, while keeping operating pretax margin and free cash flow commitments unchanged. See our latest analysis for International Business Machines. IBM’s recent revenue guidance cut sits against a mixed price backdrop, with the share price up 11.34% over 30 days yet down 18.64% year to date. The 5 year total shareholder return of...

Class action lawsuit puts recent Avis Budget Group trading under the microscope Avis Budget Group (CAR) has become the focus of fresh legal scrutiny after a new class action lawsuit accused major shareholder Pentwater Capital Management and its CEO of manipulating trading in the company’s stock. The complaint, filed in the United States District Court for the Middle District of Florida, covers investors who owned or bought Avis securities between February 20, 2025 and April 21, 2026. It...

Trade talks are reshaping the rules for global goods, and liquefied natural gas sits right in the crosshairs of that shift. With tariffs resetting and foreign governments pledging big-ticket energy commitments, some U.S. LNG exporters now face very different risk and revenue paths than they did a year ago. This article walks through three stocks exposed to the latest trade moves and shows how the same headlines can create opportunity or caution. The stocks below are just a starting sample,...

Travere Therapeutics recently reported that FILSPARI’s launch in FSGS is outperforming expectations with broad physician demand across a U.S. pool of more than 30,000 biopsy-confirmed patients. The company is also pushing its rare disease pipeline forward with a Phase III trial of pegtibatinase in classical homocystinuria and adding civorebrutinib for multiple renal indications affecting roughly 130,000 patients, underscoring a widening kidney-focused franchise. We’ll now examine how...

Simply Good Foods (NasdaqCM: SMPL) faces a new class action lawsuit alleging that the integration of its OWYN acquisition was misrepresented and ultimately unsuccessful. Investors claim the OWYN deal led to substantial impairment charges, missed integration goals and further strain on existing operational issues. The suit alleges undisclosed managerial turnover, product quality problems, margin erosion and heavy promotional activity tied to the OWYN business. These claims introduce...

BILL Holdings, Inc. recently reported fourth-quarter 2026 results, with revenue of US$436.19 million and a net loss of US$18.48 million, and issued first-quarter 2027 revenue guidance of US$432.5 million to US$442.5 million alongside full-year 2027 guidance of US$1.81 billion to US$1.86 billion. The company also completed a US$300 million buyback of 8,400,000 shares, equal to 8.44% of its share count, while swinging from full-year net income to a net loss. We’ll now examine how BILL’s...

G-III Apparel Group (GIII) is drawing fresh attention after recent share price moves, with the stock last closing at US$34.10. You might be weighing what that means for value and risk today. See our latest analysis for G-III Apparel Group. G-III Apparel Group’s recent 1-day share price return of 1.13% and 90-day share price return of 11.91% come alongside a 1-year total shareholder return of 33.22%. This suggests momentum that has been building rather than fading. If you want to see what...

Teva Pharmaceutical Industries (NYSE:TEVA) announced that the U.S. FDA has accepted its New Drug Application for ecopipam for pediatric Tourette syndrome with Priority Review status. Ecopipam is described by Teva as a first in class therapy candidate targeting children and adolescents with Tourette syndrome, an area where no new treatments have been approved in over a decade. The filing is backed by positive late stage clinical trial data and adds another potential branded medicine to Teva's...

We wouldn't blame Merck & Co., Inc. ( NYSE:MRK ) shareholders if they were a little worried about the fact that Richard...

Interest rates that stay higher for longer can unsettle markets, yet they also reshape where the potential rewards and risks sit. With the Fed’s real policy rate still below estimates of neutral, investors face a world where borrowing costs may stay elevated and old playbooks may not work as well. This article unpacks that backdrop and highlights 3 US financial stocks related to this theme for your watchlist. The three stocks covered below are just a sample of this theme. The full screen...

Global yields have recently eased as major central banks adjust liquidity tools, which has helped support appetite for higher growth opportunities. That backdrop puts extra focus on companies where analysts already expect strong earnings growth and solid balance sheets. This article looks at three stocks from the Healthy high growth potential screener that match that profile and explains what sets each one apart so you can judge whether they deserve a place on your radar. The stocks covered...